Skip to Main Content

Author Details

Valerie Rhenius
University of Cambridge
2013
23
14
PMIDPaper TitleJournal TitlePublished Year
36824750Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.Res Sq2023
37789226Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer.Eur J Epidemiol2023
37451831Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.J Med Genet2023
37444426Spectrum and Frequency of Germline <i>FANCM</i> Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.Cancers (Basel)2023
36707629FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.Eur J Hum Genet2023
33471991Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.N Engl J Med2021
33500318Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.Cancer Epidemiol Biomarkers Prev2021
34407845Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.Breast Cancer Res2021
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
32555365Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.Br J Cancer2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
29915430A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.Nat Genet2018
29262523<i>PHIP</i> - a novel candidate breast cancer susceptibility locus on 6q14.1.Oncotarget2017
28283652<i>BRCA2</i> Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.Cancer Res2017
29059683Association analysis identifies 65 new breast cancer risk loci.Nature2017
29058716Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.Nat Genet2017
27716369Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium.Breast Cancer Res2016
27640304Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.Am J Hum Genet2016
27601076Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.Nat Commun2016
26152742Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium.Clin Cancer Res2015
26674097A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.BMC Cancer2015
26317411SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival.Oncotarget2015
24138508GPAQ-R: development and psychometric properties of a version of the general practice assessment questionnaire for use for revalidation by general practitioners in the UK.BMC Fam Pract2013
  • 1 - 23 of 23

Recommended Authors

Lunenfeld-Tanenbaum Research Institute
Career Start Year 2014
Number of shared co-authors 1
National Cancer Institute, National Institutes of Health
Career Start Year 2014
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 0
Netherlands Cancer Institute
Career Start Year 2012
Number of shared co-authors 19
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
F Hoffmann-La Roche Ltd
Career Start Year 2010
Number of shared co-authors 4
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2009
Number of shared co-authors 128
The Ohio State University
Career Start Year 2007
Number of shared co-authors 131
University of California san francisco
Career Start Year 2007
Number of shared co-authors 3
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 48
Duke University
Career Start Year 2005
Number of shared co-authors 14
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year 2005
Number of shared co-authors 25
National Cancer Institute
Career Start Year 2004
Number of shared co-authors 32
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 92
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 15
University of Dhaka
Career Start Year 2004
Number of shared co-authors 0
Washington University
Career Start Year 2003
Number of shared co-authors 6
University of California
Career Start Year 2003
Number of shared co-authors 1
Queen's University
Career Start Year 2002
Number of shared co-authors 0
Oncode Institute, The Netherlands Cancer Institute
Career Start Year 2002
Number of shared co-authors 8
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 12
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 46
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 2
Memorial University
Career Start Year 1999
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 54
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 12
Dana Farber Cancer Institute.
Career Start Year 1997
Number of shared co-authors 11
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 74
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Career Start Year 1991
Number of shared co-authors 110
Institute of Cancer Research
Career Start Year 1991
Number of shared co-authors 89

Collaborators

German Cancer Research Center (DKFZ)
Co-authored papers 22
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 22
Otto-Friedrich-University Bamberg
Co-authored papers 20
Pomeranian Medical University
Co-authored papers 19
Co-authored papers 18
Co-authored papers 17
National Cancer Institute
Co-authored papers 17
University of Cambridge
Co-authored papers 16
University of Toronto
Co-authored papers 16
Faculty of Clinical Medicine, University of Oslo
Co-authored papers 15
Mayo Clinic
Co-authored papers 14
The Usher Institute, The University of Edinburgh
Co-authored papers 13
Co-authored papers 13
Instituto de Salud Carlos III
Co-authored papers 12
Co-authored papers 12
Ospedale Circolo e Fondazione Macchi
Co-authored papers 12
QIMR Berghofer Medical Research Institute
Co-authored papers 12
Co-authored papers 12
University of California irvine
Co-authored papers 12
University of Southern California
Co-authored papers 11
German Cancer Research Center (DKFZ)
Co-authored papers 11
Co-authored papers 11
Co-authored papers 10
University of Southern California
Co-authored papers 9
National Cancer Institute
Co-authored papers 8
College of Nursing, University of South Florida
Co-authored papers 8
Co-authored papers 8
Mayo Clinic
Co-authored papers 7
QIMR Berghofer Medical Research Institute
Co-authored papers 7
Co-authored papers 7